The Speeding Therapy Access Today, or STAT Act, H.R. 1730/S. 670, is a bipartisan bill that was created with the input of the rare disease community aimed at improving the development of and access to therapies for the rare disease community. The centerpiece of the STAT Act is the creation of a Rare Disease Center of Excellence at the US Food and Drug Administration. The STAT Act will:
• Accelerate rare disease therapy development,
• Optimize interagency coordination,
• Advance science-based regulatory policies, and
• Facilitate access to therapies.
Learn more at StatAct.org.